June 2025

Clinical trial finance specialist managing milestone payments and ASC 606 accounting using automated software dashboards

The Silent Crisis in Biotech Finance: How Blockchain Fixes Biotech and CRO Accounting Challenges

The Silent Crisis in Biotech Finance: How Blockchain Fixes CRO Accounting Challenges The Silent Crisis in Biotech Finance: How Blockchain Fixes CRO Accounting Challenges Leading biotech organizations are pushing boundaries in therapeutic innovation, advancing cell therapies, rare disease interventions, and precision medicine. AI-powered drug discovery platforms are identifying viable targets faster than ever before. Adaptive […]

The Silent Crisis in Biotech Finance: How Blockchain Fixes Biotech and CRO Accounting Challenges Read More »

Business professionals collaborating on a holographic display visualizing real-world asset tokenization with charts representing tokenized assets like real estate and bonds.

The $16 Trillion Shift: Why Real World Asset Tokenization is Redefining Institutional Finance

In 2025, the most significant opportunity in institutional finance isn’t a new algorithm or trading strategy. It’s an infrastructure upgrade. Boston Consulting Group projects that the market for tokenized illiquid assets will reach $16 trillion by 2030. This isn’t just a trend; it’s a fundamental re-plumbing of capital markets. For decades, the highest-value real-world assets

The $16 Trillion Shift: Why Real World Asset Tokenization is Redefining Institutional Finance Read More »

Scroll to Top